Oramed Pharmaceuticals Inc (ORMP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.17B
EV to revenue ratio (TTM)
24.02
EV to ebitda
1.52
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
$0B
EBITDA
-$0.01B
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-3.42%
Return on equity (TTM)
74.20%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
$4.13
Diluted EPS (TTM)
$4.13
Book value
$7.68
Dividend per share
$0
Dividend yield
<0.01%
Valuation Multiples
P/E ratio
1
Trailing P/E
1
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
n/a
Price to book ratio (TTM)
0.52
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
493.50%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
1.28